Skip to content
Home/Companies/Biotech/PAGE Therapeutics AG

PAGE Therapeutics AG

Biotech·Switzerland·Active·3yr hold
Entry
2023
Hold
3yr
Status
Active

Who owns PAGE Therapeutics AG?

PAGE Therapeutics AG is currently owned by KIZOO Technology Capital through KIZOO Evergreen (Balance Sheet) (2007 vintage), since 2023.

Hand-verified · updated 2026-09-29

KIZOO Technology Capital
Investor
KIZOO Technology Capital
KIZOO Evergreen (Balance Sheet) · 2007 · Evergreen

Key facts

HQSwitzerland
SectorBiotech
StatusActive

More from KIZOO Evergreen (Balance Sheet)

Other portfolio companies in the same fund.

Reservoir Neuroscience
Active
BiotechUS· 2024
MoglingBio
Active
BiotechGermany· 2022
Cellvie
Cellvie
Active
BiotechSwitzerland· 2021
Elastrin Therapeutics
Elastrin Therapeutics
Active
BiotechUS· 2021
Revel Pharmaceuticals
Revel Pharmaceuticals
Active
BiotechUS· 2020
Cyclarity Therapeutics
Cyclarity Therapeutics
Active
BiotechUS· 2019

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue